Jardiance 10 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FA3L0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,970
Award facts
- Contract value 100% obligated
- $17,970.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, issued on January 23, 2026, awards AmerSourceBergen Drug Corp $17,970.11 to supply 90-count bottles of Jardiance 10 mg tablets through the Defense Logistics Agency (DLA). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be completed by January 26, 2026, with fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement that extends through December 2026 and authorizes AmerSourceBergen to supply a comprehensive range of medications and medical supplies to support military healthcare programs globally.
Jardiance (empagliflozin) is a prescription diabetes medication used in the management of type 2 diabetes and heart failure. The DLA procures pharmaceutical products through its Medical Supply Chain to support the Defense Health Agency and military treatment facilities worldwide. AmerSourceBergen's parent organization, Cencora, Inc., maintains the primary IDC with DLA Troop Support and holds additional contracting authority through the Department of Justice Federal Bureau of Investigation for medical commodities, positioning the company as a critical vendor within the federal pharmaceutical distribution network.
Quick answers
Who was awarded contract SPE2DR26FA3L0?
SPE2DR26FA3L0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FA3L0 worth?
The government has obligated $17,970 on SPE2DR26FA3L0.
Is contract SPE2DR26FA3L0 an order under another contract?
Yes. SPE2DR26FA3L0 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA3L0 competed?
The extent of competition for SPE2DR26FA3L0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award